The risk of Guillain-Barré syndrome after tetanus-toxoid-containing vaccines in adults and children in the United States.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 9431302.
- Also identified by PMC identifier 1381255.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examined whether there is a risk that tetanus-toxoid-containing vaccines could cause Guillain-Barré syndrome and, if so, how large the risk is. This study was based on previous active surveillance epidemiological studies of Guillain-Barré syndrome and vaccination history. A background rate of 0.3 cases of Guillain-Barré syndrome per million person-weeks has been estimated. By chance, 2.2 people with the syndrome would have received tetanus-toxoid-containing vaccine within the 6 weeks before onset, yet only 1 person had done so. Data on children show similar results. If an association exists, it must be extremely rare and not of public health significance.
Medical subject headings
- Polyradiculoneuropathy
- Tetanus Toxoid